Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 12,454.80 -74.92 -0.60%
S&P 500 1,317.82 -2.86 -0.22%
Nasdaq 2,837.53 -1.85 -0.07%
Ticker Volume Price Price Delta
STOXX 50 2,161.87 +5.35 0.25%
FTSE 100 5,351.53 +1.48 0.03%
DAX 6,339.94 +24.05 0.38%
Ticker Volume Price Price Delta
Nikkei 8,580.39 +17.01 0.20%
TOPIX 722.11 -0.14 -0.02%
Hang Seng 18,713.40 +47.01 0.25%
Gold 1,576.70 +0.35%
EUR-USD 1.2570 0.1229%
Nasdaq 2,837.53 -0.07%
DJIA 12,454.80 -0.60%
S&P 500 1,317.82 -0.22%
FTSE 100 5,351.53 +0.03%
STOXX 50 2,161.87 +0.25%
DAX 6,339.94 +0.38%
Oil (WTI) 91.28 +0.46%
U.S. 10-year 1.738% -0.039
BAC:US 7.15 +0.14%
FB:US 31.91 -3.39%
  • Exchange: SIX Swiss Ex
  • Sector: Consumer, Non-cyclical
  • Industry: Healthcare-Products
  • Sub-Industry: Medical Products

Straumann Holding AG

Add to Portfolio

STMN:SW

158.30 CHF 0.20 0.13%

As of 11:31:31 ET on 05/25/2012.

Snapshot for Straumann Holding AG (STMN)

Open: 157.70 Day's Range: 155.60 - 159.90 Volume: 26,343 Bid: 158.10
Previous Close: 158.10 52wk Range: 129.07 - 233.30 1-Yr Rtn: -30.04% Ask: 158.30

Stock Chart for STMN

No chart data available.
  • STMN:SW 158.30
  • 1D
  • 1M
  • 1Y
158.10
Interactive STMN Chart

Previous Close

Key Statistics for STMN

Current P/E Ratio (ttm) 34.9448
Estimated P/E (12/2012) 22.1059
Earnings Per Share (CHF) (ttm) 4.5300
Est. EPS (CHF) (12/2012) 7.1610
Est. PEG Ratio 0.9932
Market Cap (M CHF) 2,481.60
Shares Outstanding (M) 15.68
Enterprise Value (M CHF) (ttm) 2,105.38
Enterprise Value/EBITDA (ttm) 18.03
Price/Book (mrq) 3.6502
Price/Sale (ttm) 3.5707
Dividend Indicated Gross Yield 1.3898
Next Earnings Announcement 08/21/2012
More STMN Key Statistics mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Financials for STMN

  • Revenue
  • Net Income (M/CHF)
  • Profit Margin (%)
More STMN Income Statement Data
  • Total Assets
  • Total Liabilities (M/CHF)
  • Debt to Assets (%)
More STMN Balance Sheet Data
  • Operating
  • Investing
  • Financing (M/CHF)
More STMN Cash Flow Data

Company Profile & Key Executives for STMN

Straumann Holding AG develops, produces and sells dental implants. The Company manufactures metal devices implantable in the jaw, in place of missing teeth, to which prosthetic teeth are attached. Straumann has subsidiaries throughout Europe and North America. The Company sells its products worldwide.

Gilbert AchermannChairmanThomas StraumannVice Chairman
Beat SpalingerPresident/CEOThomas DressendorferChief Financial Officer
More Company Profile & Key Executives for STMN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Advertisements